Fitness outcomes from a randomised controlled trial of exercise training for men with prostate cancer: the ENGAGE study

Journal of Cancer Survivorship

Volumn 10, Issue 6, 2016, Pages 972-980

  Gaskin, Cadeyrn J ^a   Fraser, Steve F ^b   Owen, Patrick J ^b   Craike, Melinda ^a,c   Orellana, Liliana ^a   Livingston, Patricia M ^a  

^a DEAKIN UNIVERSITY   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c VICTORIA UNIVERSITY   (Australia)

Author keywords

Aerobic exercise training; Androgen deprivation therapy; Fitness; Physical function; Prostate cancer; Resistance exercise training

Indexed keywords

AGED; CONTROLLED STUDY; EXERCISE; HUMAN; KINESIOTHERAPY; MALE; MORTALITY; PHYSIOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURVIVOR; TREATMENT OUTCOME;

AGED; EXERCISE; EXERCISE THERAPY; HUMANS; MALE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SURVIVORS; TREATMENT OUTCOME;

EID: 84964345471     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-016-0543-6     Document Type: Article

References (47)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86. doi:10.1002/ijc.29210.
2. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. Ca Cancer J Clin. 2014;64:9–29. doi:10.3322/caac.21208.
3. Jung K-W, Won Y-J, Kong H-J, Oh C-M, Shin A, Lee J-S. Survival of Korean adult cancer patients by stage at diagnosis, 2006–2010: national cancer registry study. Cancer Res Treat. 2013;45:162–71. doi:10.4143/crt.2013.45.3.162.
4. Australian Institute of Health and Welfare. Cancer in Australia: an overview 2014 (Cancer series No 90. Cat. no. CAN 88). Canberra: AIHW2014.
5. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med. 2008;148:435–48. doi:10.7326/0003-4819-148-6-200803180-00209.
6. Langston B, Armes J, Levy A, Tidey E, Ream E. The prevalence and severity of fatigue in men with prostate cancer: a systematic review of the literature. Support Care Cancer. 2013;21:1761–71. doi:10.1007/s00520-013-1751-5.
7. Watts S, Leydon G, Birch B, Prescott P, Lai L, Eardley S, et al. Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2014;4(3):e003901-e. doi:10.1136/bmjopen-2013-003901.
8. Singh J, Trabulsi EJ, Gomella LG. The quality-of-life impact of prostate cancer treatments. Curr Urol Rep. 2010;11(3):139–46. doi:10.1007/s11934-010-0103-y.
9. Taylor LG, Canfield SE, Du XL. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer. 2009;115:2388–99. doi:10.1002/cncr.24283.
10. Storer TW, Miciek R, Travison TG. Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy. Asian J Androl. 2012;14:204–21. doi:10.1038/aja.2011.104.
11. Skolarus TA, Wolf AMD, Erb NL, Brooks DD, Rivers BM, Underwood W, et al. American Cancer Society prostate cancer survivorship care guidelines. Ca Cancer J Clin. 2014;64:225–49. doi:10.3322/caac.21234.
12. Hasenoehrl T, Keilani M, Sedghi Komanadj T, Mickel M, Margreiter M, Marhold M, et al. The effects of resistance exercise on physical performance and health-related quality of life in prostate cancer patients: a systematic review. Support Care Cancer. 2015;23:2479–97. doi:10.1007/s00520-015-2782-x.
13. Baumann F, Zopf E, Bloch W. Clinical exercise interventions in prostate cancer patients—a systematic review of randomized controlled trials. Support Care Cancer. 2012;20:221–33. doi:10.1007/s00520-011-1271-0.
14. Gardner JR, Livingston PM, Fraser SF. Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review. J Clin Oncol. 2014;32:335–46. doi:10.1200/jco.2013.49.5523.
15. Culos-Reed SN, Robinson JW, Lau H, Stephenson L, Keats M, Norris S, et al. Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention. Support Care Cancer. 2010;18:591–9. doi:10.1007/s00520-009-0694-3.
16. Galvão DA, Spry N, Denham J, Taaffe DR, Cormie P, Joseph D, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol. 2014;65:856–64. doi:10.1016/j.eururo.2013.09.041.
17. Bourke L, Gilbert S, Hooper R, Steed LA, Joshi M, Catto JWF, et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol. 2014;65:865–72. doi:10.1016/j.eururo.2013.09.040.
18. Hansen PA, Dechet CB, Porucznik CA, LaStayo PC. Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot study. PMR. 2009;1:1019–24. doi:10.1016/j.pmrj.2009.09.016.
19. Alberga AS, Segal RJ, Reid RD, Scott CG, Sigal RJ, Khandwala F, et al. Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer. Support Care Cancer. 2012;20:971–81. doi:10.1007/s00520-011-1169-x.
20. Bourke L, Boorjian SA, Briganti A, Klotz L, Mucci L, Resnick MJ, et al. Survivorship and improving quality of life in men with prostate cancer. Eur Urol. 2015;68:374–83. doi:10.1016/j.eururo.2015.04.023.
21. Livingston PM, Salmon J, Courneya KS, Gaskin CJ, Craike M, Botti M, et al. Efficacy of a referral and physical activity program for survivors of prostate cancer [ENGAGE]: rationale and design for a cluster randomised controlled trial. BMC Cancer. 2011;11:237. doi:10.1186/1471-2407-11-237.
22. Livingston PM, Craike M, Salmon J, Courneya KS, Gaskin CJ, Fraser SF, et al. Effects of a clinician referral and exercise program for men who have completed active treatment for prostate cancer: a multicentre cluster randomized controlled trial (ENGAGE). Cancer. 2015;121:2646–54. doi:10.1002/cncr.29385.
23. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42:1409–26. doi:10.1249/MSS.0b013e3181e0c112.
24. Hayes SC, Spence RR, Galvão DA, Newton RU. Australian association for exercise and sport science position stand: optimising cancer outcomes through exercise. J Sci Med Sport. 2009;12:428–34. doi:10.1016/j.jsams.2009.03.002.
25. American College of Sports Medicine. ACSM’s resource manual for guidelines for exercise testing and prescription. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2010.
26. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care. 2002;166:111–7. doi:10.1164/ajrccm.166.1.at1102.
27. Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999;70:113–9. doi:10.1080/02701367.1999.10608028.
28. Duncan PW, Weiner DK, Chandler J, Studenski S. Functional reach: a new clinical measure of balance. J Gerontol. 1990;45:M192–7. doi:10.1093/geronj/45.6.M192.
29. Marfell-Jones M, Olds T, Steckler A, Carter L. International standards for anthropometric assessment. Potchefstroom, South Africa: The International Society for the Advancement of Kinanthropometry. 2006.
30. Schafer JL. Analysis of incomplete multivariate data. New York: Chapman & Hall; 1997.
31. Hommel G. A stagewise rejective multiple test procedure based on a modified Bonferroni test. Biometrika. 1988;75:383–6. doi:10.1093/biomet/75.2.383.
32. Olejnik S, Li J, Supattathum S, Huberty CJ. Multiple testing and statistical power with modified Bonferroni procedures. J Educ Behav Stat. 1997;22:389–406. doi:10.3102/10769986022004389.
33. Coombes JS, Law J, Lancashire B, Fassett RG. “Exercise is medicine”: curbing the burden of chronic disease and physical inactivity. Asia Pac J Public Health. 2015;27:NP600–5. doi:10.1177/1010539513481492.
34. Levy WC, Cerqueira MD, Harp GD, Johannessen K-A, Abrass IB, Schwartz RS, et al. Effect of endurance exercise training on heart rate variability at rest in healthy young and older men. Am J Cardiol. 1998;82:1236–41. doi:10.1016/S0002-9149(98)00611-0.
35. Perera S, Mody SH, Woodman RC, Studenski SA. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc. 2006;54:743–9. doi:10.1111/j.1532-5415.2006.00701.x.
36. Alibhai SMH, Breunis H, Timilshina N, Naglie G, Tannock I, Krahn M, et al. Long-term impact of androgen-deprivation therapy on physical function and quality of life. Cancer. 2015;121:2350–7. doi:10.1002/cncr.29355.
37. Joly F, Alibhai SMH, Galica J, Park A, Yi QL, Wagner L, et al. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. J Urol. 2006;176:2443–7. doi:10.1016/j.juro.2006.07.151.
38. Norris MK, Bell GJ, North S, Courneya KS. Effects of resistance training frequency on physical functioning and quality of life in prostate cancer survivors: a pilot randomized controlled trial. Prostate Cancer Prostatic Dis. 2015;18:281–7. doi:10.1038/pcan.2015.28.
39. Visser M, Goodpaster BH, Kritchevsky SB, Newman AB, Nevitt M, Rubin SM, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol. 2005;60:324–33.
40. Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol. 2006;61:72–7.
41. Cormie P, Galvão DA, Spry N, Joseph D, Chee R, Taaffe DR, et al. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial. BJU Int. 2015;115:256–66. doi:10.1111/bju.12646.
42. Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review and meta‐analysis. J Am Heart Assoc. 2013;2, e004473. doi:10.1161/jaha.112.004473.
43. Taylor BC, Wilt TJ, Welch HG. Impact of diastolic and systolic blood pressure on mortality: implications for the definition of “normal”. J Gen Intern Med. 2011;26:685–90. doi:10.1007/s11606-011-1660-6.
44. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–20. doi:10.1001/jama.2013.284427.
45. Basaria S, Lieb J, Tang AM, DeWeese T, Carducci M, Eisenberger M, et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol. 2002;56:779–86. doi:10.1046/j.1365-2265.2002.01551.x.
46. Clay CA, Perera S, Wagner JM, Miller ME, Nelson JB, Greenspan SL. Physical function in men with prostate cancer on androgen deprivation therapy. Phys Ther. 2007;87:1325–33. doi:10.2522/ptj.20060302.
47. Lynch BM, Dunstan DW, Winkler E, Healy GN, Eakin E, Owen N. Objectively assessed physical activity, sedentary time and waist circumference among prostate cancer survivors: findings from the National Health and Nutrition Examination Survey (2003–2006). Eur J Cancer Care. 2011;20:514–9. doi:10.1111/j.1365-2354.2010.01205.x.